UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.
Vous n'êtes pas connecté
New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can lead
UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.
Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.
Current prostate cancer tests may fail to detect early-stage disease in transgender women, potentially leading to delayed diagnosis and treatment.
A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...
MONDAY, July 1, 2024 -- Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns. Prostate cancer...
THURSDAY, June 27, 2024 -- Acupuncture can help breast cancer patients deal with the hot flashes that often accompany hormone therapy, a new clinical...
Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...
In a pooled analysis of three clinical trials, acupuncture significantly reduced hot flashes and other hormonal side effects of endocrine therapy...
Menopause used to be a taboo topic in many quarters. Now, it’s frequently in the news.In March 2024, the White House announced an initiative to...
Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...